Gene Therapy Market to Garner $6.21 Bn, Globally, by 2026 at 34.8% CAGR, Says Allied Market Research
High investment in R&D activities, increase in prevalence of cancer, and growth in awareness regarding gene therapy drive the growth of the global gene therapy market
PORTLAND, Oregon, Dec. 16, 2019 /PRNewswire/ -- Allied Market Research recently published a report, titled, "Gene Therapy Market by Vector Type (Viral Vector and Non-viral Vector), Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth Factors, Receptors, and Others), and Application (Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Disease, and Other Diseases): Global Opportunity Analysis and Industry Forecast, 2019–2026". According to the report, the global gene therapy industry was pegged at $393.35 million in 2018, and is projected to reach $6.21 billion by 2026, registering a CAGR of 34.8% from 2019 to 2026.
Prime determinants for growing market
High investment in R&D activities, increase in prevalence of cancer, and growth in awareness regarding gene therapy have boosted the growth of the global gene therapy market. However, high costs associated with gene therapies and unwanted immune responses hamper the market growth. On the contrary, untapped potential for the emerging market is expected to create lucrative opportunities in the near future.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/2841
Viral vector segment dominated the market
The viral vector segment held the largest share in 2018, contributing to more than half of the global gene therapy market, owing to easier modifications of many viruses such as Lentivirus, Adeno-Associated Virus (AAV), RetroVirus & Gamma RetroVirus to deliver gene therapy drugs. However, the non-viral vector segment is expected to register the fastest CAGR of 38.8% during the forecast period. This is attributed to the technological advancements in physicochemical approaches such as physical methods and chemical methods of non-viral vectors.
Tumor suppressor segment to manifest fastest CAGR through 2026
The tumor suppressor segment to portray the fastest CAGR of 52.9% during the forecast period, owing to rise in number of methodology and clinical trials of tumor suppressor for the gene therapy treatment. However, the antigen segment held the largest share in 2018, contributing to more than one-fifth of the global gene therapy market, due to the presence of a wide range of genetic mutations and dysregulated gene expression of tumor cells.
North America held the lion's share
The global gene therapy market across North America held the largest share in 2018, accounting for nearly half of the market, owing to high prevalence rate of cancer, presence of high disposable income, and increase in funding for R&D activities associated with gene therapy. However, the market across the Asia-Pacific region is projected to register the fastest CAGR of 45.4% during the forecast period, owing to rise in number of people prone to various chronic diseases and approval & launch of gene therapy products.
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/2841
Major market players
- Adaptimmune Therapeutics Plc.
- Achieve Life Sciences, Inc.
- Anchiano Therapeutics Ltd.
- Abeona Therapeutics Inc.
- Adverum Biotechnologies, Inc.
- Arbutus Biopharma Corporation
- Applied Genetic Technologies Corporation
- AveXis, Inc.
- Audentes Therapeutics, Inc.
- Celgene Corporation
- Bluebird Bio, Inc.
- Editas Medicine, Inc.
- CRISPR Therapeutics AG
- GlaxoSmithKline Plc.
- Editas Medicine, Inc.
- Merck & Co., Inc.
- Intellia Therapeutics, Inc.
- REGENXBIO Inc.
- Novartis AG
- Sangamo Therapeutics, Inc.
- Spark Therapeutics, Inc.
- Uniqure N. V.
- Voyager Therapeutics, Inc.
Access KNOWLEDGE TREE (Premium on-demand, subscription-based pricing model) at: https://www.alliedmarketresearch.com/knowledgetree
Knowledge tree is a cloud-based intelligence platform that offers more than 2,000 selective, off-the-shelf reports on niche markets to enable our clients gain deep insights on the latest trends, dynamic technologies, and emerging application areas.
Get Up to 30% Discount on All Published Reports:
DNA sequencing Market: Global Opportunity Analysis and Industry Forecast, 2017 - 2025
Digital PCR Market: Global Opportunity Analysis and Industry Forecast, 2018 – 2025
Pre-Book Now with 12% Discount:
Digital PCR (dPCR) and Real-Time PCR (qPCR) Market- Global Opportunities and Forecasts, 2019-2026
Rapid Diagnostics Market - Global Opportunities and Forecasts, 2019-2026
Therapeutic Electrodes Market - Global Opportunity Analysis and Industry Forecast, 2019-2026
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research
Follow Us on Twitter: https://twitter.com/marketresearcht
Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg
Share this article